Dimorphic fungi collectively account for 5-10 million new infections annually worldwide. Ongoing efforts seek to clarify mechanisms of cellular resistance to these agents and develop vaccines. A major limitation in studying the development of protective T cells in this group of organisms is the lack of tools to detect, enumerate, and characterize fungus-specific T cells during vaccination and infection. We generated a TCR transgenic mouse (Bd 1807) whose CD4 + T cells respond to a native epitope in
Blastomyces dermatitidis and also in Histoplasma capsulatum. In this study, we characterize the mouse, reveal its applications, and extend our analysis showing that 1807 cells also respond to the related dimorphic fungi Coccidioides posadasii and Paracoccidioides lutzii. On adoptive transfer into vaccinated wild-type mice, 1807 cells become activated, proliferate, and expand in the draining lymph nodes, and they differentiate into T1 effectors after trafficking to the lung upon lethal experimental challenge. Bd 1807 cells confer vaccine-induced resistance against B. dermatitidis, H. capsulatum, and C. posadasii. Transfer of naive 1807 cells at serial intervals postvaccination uncovered the prolonged duration of fungal Ag presentation. Using 1807 cells, we also found that the administration of vaccine only once induced a maximal pool of effector/memory CD4 + cells and protective immunity by 4 wk after vaccination. The autologous adoptive transfer system described in this study reveals novel features of antifungal immunity and offers a powerful approach to study the differentiation of Ag-specific T cells responsive to multiple dimorphic fungi and the development of CD4 + T cell memory needed to protect against fungal infection. The Journal of Immunology, 2011, 187: 1421-1431.
A lthough Ab-based therapies are undergoing a renaissance, the induction of durable T cell memory is the cornerstone of vaccine immunity to fungi. The kinetics of induction and maintenance of Ag-specific CD4 + T cell memory to fungi have not been amenable to study owing to the lack of known protective Ags and clonally restricted T cells with complementary TCRs. We recently created a TCR transgenic (tg) mouse (Bd 1807) to interrogate the Ag-specific CD4 + T cell response to a natural and protective epitope of the fungal pathogen Blastomyces dermatitidis, a systemic fungal pathogen of humans and other mammals (M. Wüthrich, K. Ersland, K.J. Galles, T.D. Sullivan, and B.S. Klein, submitted for publication).
In this study, we report that 1807 cells respond well to four systemic dimorphic fungi, including B. dermatitidis, Histoplasma capsulatum, Coccidioides posadasii, and Paracoccidioides lutzii, implying that the cells recognize a shared epitope. Vaccine priming of 1807 cells protected recipient mice that lack endogenous CD4 + cells from infection with the three major systemic fungi of North America (B. dermatitidis, H. capsulatum, and C. posadasii). Using this tg mouse, we established an adoptive transfer system to follow the activation of T cells that arise in response to protective Ag. TCR tg systems such as this are among the best immunological tools to analyze naive T cell activation in vivo, since the frequency of circulating Ag-specific T cells can be raised above the level of detection for flow cytometric and immunohistological analyses (1) (2) (3) . The development of this system allowed us to track key stages of activation, differentiation, and memory T cell development during priming and recall phases of protective immunity. Naive 1807 cells were activated, proliferated, and expanded in the skin draining lymph nodes (sdLNs); however, they required trafficking to the site of vaccine delivery or the lung on experimental challenge to fully differentiate into effector cells. Bd 1807 cells also served as sentinels enabling us to define the duration of Ag persistence after vaccination and the conditions for inducing an optimal pool of effector/memory cells that mediate protective immunity to lethal experimental infection against dimorphic fungi.
Materials and Methods

Generation of the tg mouse
We described generation of the Blastomyces-specific TCR Tg 1807 mouse elsewhere (M. Wüthrich et al., submitted for publication). Briefly, we cloned the a-and b-chains of the TCR from CD4 + T cell clone no. 5, which is specific for a protective epitope of B. dermatitidis (4 ) were transferred i.v. into sublethally irradiated (5.5 Gy) C57BL/6 mice. Mice were rested for 10 wk before infection to allow lymphopenia-driven expansion of the transplant (5).
Fungi
Strains used were ATCC 26199 (6), a wild-type strain of B. dermatitidis, and the isogenic, attenuated mutant lacking BAD1, designated strain 55 (7), as well as H. capsulatum strain G217B, P. lutzii (Pb1) (8) , Paracoccidioides brasiliensis (ATCC 60855), and Candida albicans strain 5314. B. dermatitidis was grown as yeast on Middlebrook 7H10 agar with an oleic acid-albumin complex (Sigma-Aldrich) at 39˚C. H. capsulatum was grown as yeast at 37˚C and 5% CO 2 on Histoplasma macrophage medium. P. lutzii was grown in liquid brain heart infusion (Difco, Detroit, MI) at 37˚C and was rotated at 200 rpm. C. albicans was grown on yeast extract/peptone/dextrose plates. The saprobic phase of C. posadasii (isolate C735) was grown on glucose yeast extract medium (1% glucose, 0.5% yeast extract, 1.5% agar) at 30˚C for 3-4 wk to generate a confluent layer of arthroconidia (spores) on the agar surface. Formalin-killed spherules (FKS) of C. posadasii were generated as described (9, 10) . 
Mouse strains
Vaccination and infection
Mice were vaccinated twice as described (17) 5 C. albicans as described (17, (19) (20) (21) (22) (23) . To assess the infiltration of primed CD4 cells into the lungs, lung homogenates of challenged mice were analyzed at day 4 postinfection. To analyze the extent of lung infection, homogenized lungs were plated and yeast CFU enumerated on brain heart infusion agar (Difco), sheep blood-containing Mycosel plates, and on glucose yeast extract plates containing 50 mg/ml chloramphenicol (19) . Adoptive transfer of 1807 cells and experimental challenge. To determine whether 1807 cells mediate protection, we transferred 10 6 naive 1807 or OT-2 (control) tg cells into OT-1 mice before vaccination. On the same day, recipients were vaccinated with 10 6 heat-killed B. dermatitidis and H. capsulatum yeast or 10 6 FKS C. posadasii s.c. Two weeks after vaccination, the mice were challenged. Thy1.1-based enrichment and detection of lymph node cells and splenocytes. To detect transferred Thy1.1 + congenic tg cells, we used magnetic bead-based enrichment (24, 25) . To reduce the background of contaminating recipient cells, enriched cells were stained with the B cell marker B220 and analyzed by FACS. By excluding cells that bound Ab to CD4 nonspecifically, the background was reduced to virtually 0 as assessed in mice with no transfer (data not shown). This low background rate allowed detection of as few as 10 transferred cells (24, 25) . Briefly, a single-cell suspension of sdLN cells and splenocytes from one mouse was washed and resuspended in 1 ml iMag buffer containing PBS (pH 7.4), 0.5% BSA, 2 mM EDTA, and 4 ml biotinylated anti-Thy1.1 mAb (BD Biosciences). After 15 min incubation on ice, cells were washed in iMag buffer and the pellet was suspended in 250 ml streptavidin iMag particles (BD Biosciences) and incubated at 4˚C for 30 min. Bead-coated cells were enriched using direct magnetic bead separation as per the manufacturer's instructions. Enriched cells were resuspended in 250 ml iMag buffer, counted, stained, and analyzed by FACS.
Intracellular cytokine stain
Skin tissue-derived cells were collected serially after vaccination and cells from lung homogenates were harvested at day 4 postinfection. Cells (0.5 3 10 6 cells/ml) were stimulated for 4 h with anti-CD3 (clone 145-2C11; 0.1 mg/ml) and anti-CD28 (clone 37.51; 1 mg/ml) in the presence of GolgiStop (BD Biosciences). Stimulation with fungal ligands yielded comparable cytokine production by transgenic T cells compared with CD3/CD28 stimulation (data not shown). After cells were washed and stained for surface CD4 and CD8 using anti-CD4-PerCp, anti-CD8-PeCy7, anti-CD44-allophycocyanin, anti-CD62L-PE, and B220 Alexa 700 (to gate out non-T cell background) mAbs (BD Pharmingen), they were fixed and permeabilized in Cytofix/Cytoperm at 4˚C overnight. 
Statistical analysis
The number and percentage of activated, proliferating, or cytokineproducing T cells and the differences in number of CFU were compared among groups by using ANOVA models (26) . A two-sided p value ,0.05 was considered statistically significant.
Results
Bd 1807 cells recognize a shared Ag in systemic dimorphic fungi B. dermatitidis, P. brasiliensis (and P. lutzii), H. capsulatum, and Coccidioides immitis (and C. posadasii) are closely related at the level of 18S ribosomal DNA sequences (27, 28) . We recently found that Bd 1807 cells respond to a shared immunodominant Ag in B. dermatitidis and H. capsulatum (M. Wüthrich et al., submitted for publication). In this study, we extended this analysis and tested whether Bd 1807 cells may also respond to this shared Ag in C. posadasii and P. lutzii. After transferring 1807 cells into mice, we vaccinated them with C. posadasii, P. lutzii, H. capsulatum, and B. dermatitidis. We also vaccinated mice with C. albicans and P. carinii as controls for agents that are not closely related to dimorphic fungi (http://timm.main.teikyo-u.ac.jp/pfdb/ cover/taxonomic_list_eng.html). Bd 1807 cells were activated in response to the four systemic dimorphic fungi, but they were not activated in unvaccinated mice or mice vaccinated with C. albicans or P. carinii ( Fig. 1A and data not shown). More than 98% of 1807 cells proliferated and became CFSE lo in response to P. lutzii, C. posadasii, H. capsulatum, and B. dermatitidis, and the pattern for CD44 and CD62L was also comparable for the groups. Vaccinated recipients of Bd 1807 cells were challenged i.t. with the homologous (vaccinating) fungus to determine whether the cells acquired memory, differentiated, and recruited back to the lung. Bd 1807 Th1 effectors were recruited to lung in response to all four dimorphic fungi and 5-25% produced IFN-g (Fig. 1B) . Bd 1807 responses were similar to endogenous, polyclonal CD4 + T cell responses in each case, implying that the tg cells portray the endogenous response. Bd 1807 cells failed to recall in response to Candida, although endogenous CD4 + T cells produced a robust IFN-g response. These results imply that Bd 1807 cells recognize a shared Ag in four dimorphic fungi and can be used to study and compare T cell development in response to these organisms.
Precursor frequency and vaccine dose dictate proliferation and activation of 1807 cells
To establish an adoptive transfer system, we titrated precursor frequency of naive 1807 cells and vaccine dose of B. dermatitidis. The frequency of transferred T cells can affect proliferative expansion of responding T cells (24, 29) . We determined the minimum number of transferred 1807 cells, enabling us to observe , again implying that the relative expansion was maximal using 10 5 precursors for adoptive transfer.
To determine whether the vaccine dose affects proliferation and activation of naive tg precursors, we adoptively transferred 1807 cells and then vaccinated recipient mice with 10 ) were needed to promote maximal expansion at this precursor frequency. To approximate the likely frequency of endogenous T cells and to use frequencies that yielded maximal proliferation, in experiments below we transferred 10 5 Bd 1807 cells unless otherwise stated. We vaccinated mice with 10 6 yeast because that dose induced maximal proliferation and activation at this frequency.
Bd 1807 cells develop memory, migrate to the lung, and produce IFN-g after challenge
The induction of effector function and the generation of memory require a higher Ag level threshold per naive T cell precursor than does proliferation (30, 31) . For example, survival and memory generation of adoptively transferred TCR tg T cells are dependent on the number of transferred cells and the amount of Ag available per naive precursor (24, 30, 31) . Decreasing the input number of naive CD4 + T cells can promote memory development; conversely, limiting the availability of Ag can impair memory development.
To determine whether Bd 1807 tg cells develop memory, we tested a precursor frequency of 10 5 transferred cells and a vaccine dose ranging from 10 5 to 10 7 yeast. At 31 d after vaccination, the number of transferred 1807 cells in the sdLNs was significantly higher in vaccinated mice versus controls (Fig. 3A) . The pool of primed CD44
hi tg cells in all groups of vaccinated mice was 115-to 349-fold larger than in the unvaccinated controls. In contrast, the increase in the number of endogenous, polyclonal CD4 + CD44
hi T cells was ,2.4-fold higher in vaccinated versus unvaccinated mice, and the percentage of CD44 hi T cells was ,15%. In vaccinated mice, 80-92% of the transferred 1807 cells expressed high levels of CD44 versus 11% in unvaccinated control mice. Thus, the analysis of polyclonal cells did not permit detection or tracking of a memory pool, whereas transfer of 10 5 Bd 1807 precursors and ensuing vaccination induced a significant population of memory cells. This discrepancy between polyclonal and 1807 cells underscores the utility of this mouse and adoptive transfer system for interrogating Ag-specific T cell memory immunity to fungi. To determine whether memory 1807 cells migrate to the lung during pulmonary recall, we analyzed lung T cells during the first 4 d postinfection when memory T cells arrive and peak in the lung (20, 32) . In vaccinated mice, 1807 cells that produced IFN-g migrated into the lungs by day 2 and increased sharply by day 3 postinfection (Fig. 3B) . Unvaccinated mice showed no influx of IFN-g-producing tg cells during this interval. Polyclonal IFN-gproducing CD4
+ cells from vaccinated mice showed a similar kinetics of influx, indicating that 1807 cells accurately report the behavior of endogenous Ag-specific CD4 + T cells. Vaccine-induced expansion of transferred 1807 cells did not affect the recruitment of IFN-g-expressing CD4
2 cells into the lung. In unvaccinated mice infected i.t. with wild-type yeast, polyclonal CD4 + cells that produced IFN-g were detected by day 1 of infection, whereas 1807 cells were not detected. It is unclear whether these polyclonal CD4 + cells are fungus-specific. Thus, Bd 1807 cells acquired memory, were recalled to the lung upon experimental challenge, and showed fidelity with endogenous CD4 + T cells.
Persistence of fungus-derived Ag presentation
The kinetics of presentation of fungal Ag and its impact on the differentiation of CD4 + T cell effectors and generation of memory remain undefined. During an experimental influenza infection, live virus is cleared within the first 10 d of infection, but adoptive transfer of naive influenza-specific CD4 T cells indicated Ag persistence for $3 wk after virus clearance (33) . To assess the duration and relative amount of persistent vaccine Ag in this study, we used 1807 cells. We transferred the tg cells into mice at various times after Blastomyces vaccination and analyzed the donor cells for cell division and activation 7 d after transfer (33) . This approach also enabled us to compare persistence of Ag using heat-killed versus live vaccine. To confirm that 1807 cells report proliferation and activation in an Ag-specific manner, we analyzed 1807 phenotypes in vaccinated and unvaccinated recipients. Naive 1807 cells transferred into unvaccinated mice remained largely CFSE hi , CD44 lo , and CD62L
hi for most time points, but there were minor fluctuations of the phenotypic markers for individual batches of donor cells. Consequently, this unvaccinated control group was used as a baseline. To establish that the division of donor 1807 cells was Ag-specific, Ea-specific TEa cells were transferred into vaccinated controls. TEa cells did not divide or become activated, establishing that 1807 cells behaved in an Ag-specific manner (data not shown).
In response to live vaccine, 10 5 Bd 1807 cells became activated within the first 3 wk after vaccination, as noted by loss of CFSE (.90%) and expression of CD44 (.80%) (Fig. 4A and data not  shown) . Thereafter, 1807 T cell activation dwindled but was still evident by day 89 postvaccination (Fig. 4B) . At day 28 postvaccination and thereafter, T cell activation was hardly detectable with 10 5 precursors, and the lower frequency of 10 4 cells plus Thy1.1-based enrichment (24, 25) was required to detect T cell activation. Thus, the amount of vaccine Ag became limiting by 4 wk after vaccination. In mice vaccinated with heat-killed yeast, T cell priming during the first 3 wk after vaccination was comparable to that in mice with live vaccine; it was reduced thereafter and not detected .35 d after vaccination. Thus, fungal Ag persisted longer with live versus dead vaccine, and 1807 cells reported extended persistence of vaccine Ag.
We measured Ag persistence using another approach. We vaccinated mice with live yeast and measured CFU at the vaccine site (skin). Fungal CFU persisted during the first 3 wk postvaccination, and they fell consistently thereafter and were cleared completely by day 104 postvaccination (Fig. 4C) . Thus, the findings revealed with 1807 cells are consistent with these results.
Prolonged Ag exposure drives optimal T cell development
Because fungal Ag persists up to 3 mo after vaccination, we wondered what parameters are needed to drive optimal T cell priming and protection. We have used an empirical schedule of two vaccinations during 4 wk, which induces sterilizing immunity in most vaccinated mice (17, 32) . The generation of the 1807 tg mouse and an adoptive transfer system enables us to study the parameters for optimal priming of protective T cells. We studied the time interval after vaccination needed to induce maximal protection and T cell memory. In view of the persistence of vaccine Ag, we postulated that vaccine boosting might not be required. We vaccinated mice during the course of 2, 4, or 8 wk and boosted them or not to measure the size of the effector/memory T cell pool in the sdLNs. The number of primed (CD44 hi ) 1807 cells was significantly greater in all groups of vaccinated mice versus unvaccinated controls (Fig. 5A) . Mice vaccinated during 4 wk, independent of a boosting dose, harbored a significantly larger pool of effector/memory T cells than did the groups vaccinated for 2 or 8 wk. Remarkably, the number of polyclonal CD4 + CD44 hi T cells evinced only subtle increases in vaccinated mice versus unvaccinated controls. Thus, Bd 1807 cells let us monitor and quantify the emergence of Ag-specific effector/memory T cells in the sdLNs in a setting where the analysis of polyclonal T cells was uninformative. After we challenged vaccinated mice i.t., we enumerated 1807 cells that migrated to the lung and measured lung CFU in unvaccinated and vaccinated mice. Mice vaccinated during 4 wk, whether they were boosted or not, harbored 22-fold more primed 1807 cells in their lungs than mice vaccinated during 2 wk (Fig.  5B) . Whereas the number of primed polyclonal CD4 + T cells in the lung was increased in all groups of vaccinated and unvaccinated mice, the analysis of the polyclonal pool again revealed only small differences between groups. Thus, polyclonal and 1807 tg cells migrated to the lung in an Ag-specific manner, but only 1807 tg cells offered the resolving power needed to determine the vaccine conditions that optimally induce and recall memory T cells to the lung.
The number of primed 1807 cells recruited to the lung correlated with the lung burden. Mice challenged 4 wk postvaccination cleared yeast from their lungs, whereas mice that had a shorter 2-wk interval of vaccination yielded 2-3 logs higher lung CFU (Fig.  5C ). When vaccinated mice were challenged 8 wk after vaccination, they still cleared the yeast from their lungs, despite the fact that the influx of primed 1807 cells was smaller than in mice challenged 4 wk after vaccination. By 8 wk the pool of primed 1807 cell had likely contracted but retained the functional capacity of a long-term memory pool. Thus, a 4-wk interval after vaccination, independent of boosting, is necessary and sufficient to 6 heat-killed B. dermatitidis yeast twice 2 wk apart. Four weeks after the boost, mice were challenged with 26199 wild-type yeast (10 3 ) and 25 d later, when unvaccinated mice were moribund, they were analyzed for lung CFU. Wild-type mice were vaccinated or not and challenged in parallel. Data represent the geometric mean CFU 6 SEM; n = 8 mice/group. *p , 0.001 versus unvaccinated OT-1 and wild-type mice that received no TCR tg cells, **p , 0.005 versus unvaccinated mice that received 1807 or TEa cells. Bold numbers indicate the n-fold reduction in lung CFU versus control mice that received no T cells or vaccine. C, OT-1 mice received TCR tg 1807 or OT-2 cells as a control and were vaccinated (or not) with 10 6 heat-killed yeast on the day of transfer and boosted 2 wk later. Two weeks after the boost, mice were challenged with 26199 yeast (2 3 10 3 ). Nineteen and 25 d postinfection when the unvaccinated wild-type and OT-1 mice, respectively, were moribund, the lungs were harvested and plated for CFU. *p , 0.05 versus unvaccinated wild-type and OT-1 mice that received no maximally induce a pool of effector/memory T cells in the sdLNs that can efficiently migrate to the lung upon challenge to mediate sterilizing immunity against a lethal pulmonary infection.
Bd 1807 cells confer protection against multiple dimorphic fungi
Because the 1807 mouse was made from a TCR that mediates resistance to infection with B. dermatitidis (4), we sought to determine whether 1807 cells confer protection against infection. We used two approaches. First, we generated T1-polarized effector cells in vitro and transfered them into naive wild-type mice before challenge. In vitro-primed TCR tg CD4 + effector cells confer protection against lethal influenza infection (34). Naive 1807 cells were stimulated in vitro with anti-CD3 and anti-CD28 mAbs in the presence of recombinant IFN-g and anti-IL-4 mAb to polarize them into a T1 phenotype (35) . After 10 d culture, 1807 cells were polarized and produced chiefly IFN-g in cell culture supernatants, whereas nonpolarized 1807 cells produced both Th1 and T2 cytokines. Upon adoptive transfer and challenge, all three effector T cell populations reduced lung CFU significantly compared with mice that did not receive any T cells (Fig. 6A) . Thus, 1807 effector cells confer protection.
Second, we tested whether in vivo priming of 1807 cells could promote vaccine immunity. We transferred naive 1807 and TEa (irrelevant control) cells into TCR-a 2/2 mice and vaccinated them with heat-killed yeast. Heat-killed yeasts were used to avoid dissemination in immune-deficient mice (36) . Vaccination engendered robust immunity (Fig. 6B) To circumvent the limitation above, we used another design. To avoid lymphopenia-induced activation of transferred T cells, we transferred tg cells into OT-1 mice that harbor chiefly SIINFEKLspecific CD8 T cells and few endogenous CD4 + T cells (13) . Because OT-1 mice are not lymphopenic, transferred tg cells should not expand and become nonspecifically activated. To determine whether OT-1 mice that received nonspecific OT-2 cells acquire vaccine immunity, we vaccinated these mice with B. dermatitidis yeast and analyzed lung CFU after challenge. Vaccinated and nonvaccinated mice showed similar lung CFU, indicating that any endogenous cells in OT-1 mice or OT-2 donor cells do not confer immunity (Fig. 6C ). This transfer system was thus deemed suitable to assess in vivo protection by 1807 cells. OT-1 mice that received naive 1807 cells before vaccination and challenge reduced lung CFU by 3 logs versus control mice that received OT-2 cells. Transfer of naive 1807 cells without vaccination reduced lung CFU 33-fold, whereas OT-2 cells had no effect. Thus, in vivo-primed 1807 cells confer vaccine protection to B. dermatitidis and naive 1807 cells confer resistance to primary infection, but much less so. Because 1807 cells recognize a protective Ag in Blastomyces yeast that is shared in other dimorphic fungi, we tested whether 1807 cells protect against Histoplasma or Coccidioides infection. Transfer of 1807 cells into OT-1 mice vaccinated with H. capsulatum or C. posadasii reduced lung CFU significantly by 8-and 31-fold, respectively, versus vaccinated OT-1 controls (Fig. 6D, 6E) . Thus, vaccineinduced 1807 cells are sufficient to protect against experimental coccidioidomycosis and histoplasmosis.
Discussion
We describe a TCR tg mouse and its use in studying the developmental progression of fungal Ag-specific T cells. This mouse is unique and will benefit the field of medical mycologists studying cellular mechanisms of CD4 T cell immunity and memory to dimorphic fungi. First, Bd 1807 cells recognize a shared Ag in B. dermatitidis, H. capsulatum, P. brasiliensis, and C. posadasii. Because T cell responses are requisite for vaccine immunity against dimorphic fungi, investigators studying them will now have a tool to track and precisely enumerate Ag-specific T cells during development. Second, Bd 1807 cells report a biologically vital endpoint, as they harbor a TCR from cells that protects against experimental infection. Bd 1807 cells themselves protect vaccinated mice against infection. Thus, Bd 1807 cells and the adoptive transfer system we developed produce functional T cells that differentiate, develop memory, and protect against experimental pulmonary blastomycosis, histoplasmosis, and coccidiomycosis. To our knowledge, this is the first anti-fungal TCR tg mouse that harbors protective T cells. Although Af3.16 TCR tg T cells are specific for A. fumigatus and migrate, proliferate, and differentiate in an Ag-specific manner, their protective role was not investigated (3) . The ability of Bd 1807 cells to confer resistance to infection with the three major endemic, dimorphic fungi of North America should allow us and others to study the role of CD4 + T cell differentiation down varied T helper pathways in generation of long-term memory and immunity to fungal disease.
The TCR tg mouse and adoptive transfer system in this study enabled us to analyze T cells at a level that has not been readily attainable in fungal immunology (3). We used 1807 tg cells to address two simple questions about Ag persistence and optimal conditions for vaccine immunity. First, we studied how long Ag persists after immunization with live or heat-killed vaccine. We used naive 1807 cells as a sentinel, transferring them into vaccinated mice at serial time points postvaccination to assess T cell activation and proliferation 1 wk later. T cells proliferated and TCR tg cells, **p , 0.05 versus vaccinated OT-1 mice that received OT-2 cells prior to vaccination. D and E, OT-1 mice received TCR tg 1807 or OT-2 cells as a control and were vaccinated (or not) with 10 6 heat-killed H. capsulatum yeast or 10 6 FKS from C. posadasi on the day of transfer and boosted 2 wk later. Two weeks after the boost, mice were challenged with 2 3 10 5 H. capsulatum yeast (strain G217B) or 60 viable spores of C. posadasii (isolate C735). Fourteen days postinfection when the unvaccinated wild-type and OT-1 mice, respectively, were moribund, the lungs were harvested and plated for CFU. *p , 0.05 versus unvaccinated wild-type and OT-1 mice that received no TCR tg cells, **p , 0.05 versus vaccinated OT-1 mice that received OT-2 cells prior to vaccination. became activated for up to 2 or 3 mo postvaccination using heatkilled or live vaccine, respectively. In the case of the live vaccine, CFU plating of skin tissue harvested from the vaccine site confirmed the prolonged presence of Ag reported by sentinel 1807 cells. The persistence of fungal Ag contrasts with influenza where viral Ag persisted for several weeks after viral clearance as detected by HNT-specific TCR tg T cells (33) . Bd 1807 cells did not report persistent fungal Ag after CFU clearance. The Ag load might be higher after systemic viral infection as opposed to a local fungal vaccine administration. If so, the amount of Ag available per naive TCR tg precursor would be lower in our fungal model. This hypothesis was supported by the fact that T cell proliferation and activation after 21 d postvaccination was only detectable when we transferred fewer (10 4 ) naive 1807 cells and enriched them with beads (24) .
We asked what vaccine schedule drives the largest effector/ memory pool of Ag-specific T cells that mediates protective immunity. The increase in number of primed Ag-specific T cells in vaccinated versus unvaccinated mice was more than one magnitude larger for the 1807 cells than for polyclonal CD4 + cells. The number of primed 1807 cells detected in the sdLNs and lung after recall was the largest in mice vaccinated during a period of 4 wk, demonstrating that this interval induces a maximal pool of effector/memory cells. To evaluate the utility and fidelity of the mouse in monitoring Ag-specific T cells, we compared 1807 tg cells and polyclonal CD4 + T cells during sequential stages after vaccination: activation, differentiation, memory, and protection. We established an adoptive transfer system and defined the conditions that induce optimal activation and expansion of the TCR tg T cells. Bd 1807 tg cells expanded maximally using a precursor frequency of 10 5 tg cells and a vaccine dose of 10 6 -10 7 yeast. Therein, .90% of 1807 cells were activated, and they proliferated and expanded at a maximum by 2000-to 5800-fold. At either higher or lower precursor frequencies, the maximal expansion of T cells and their activation and proliferation, as denoted by the number and percentage of CD44 hi cells or CFSE lo cells, were all reduced. Considering that ∼10-15% of the transferred precursors (∼10 4 cells) survive transplantation (24, 29, 38) , we could have created a nonphysiological situation wherein transferred 1807 tg cells exceeded the pool size of endogenous naive Ag-specific T cells. The largest pool of such cells known so far is ∼1200 cells per mouse (25, (39) (40) (41) ; however, only a handful of the estimated 10 6 endogenous Ag-specific precursor populations have been measured (42) . Thus, it is unknown whether larger populations exist in the normal repertoire. Because 10 5 precursors induced the most robust expansion and activation of 1807 cells in our model, we used this frequency in our studies to evaluate downstream T cell functions of differentiation, memory, and protection.
Memory CD4 + T cells developed in the sdLNs when we transferred 10 5 Bd 1807 cells prior to vaccination. Vaccinated mice had .100-fold more primed (CD44 hi ) TCR tg cells than did unvaccinated mice, and the percentage of CD44 hi cells in the respective groups was .80% versus ,15%. Importantly, analysis of polyclonal CD4 + T cells did not permit the detection of Agspecific memory. The number of primed polyclonal CD4 T cells migrated to the lung and produced IFN-g upon pulmonary challenge. Transferring 10 5 naive precursors yielded 500-1500 CD44 hi 1807 cells in the lung of which 58-170 cells produced IFN-g. A lower precursor frequency did not yield a detectable number of IFN-g-producing 1807 cells in the lung upon challenge. Thus, even though we transferred 1807 cells at a frequency that may have exceeded a natural precursor frequency, the tg cells differentiated, became memory cells, and migrated to the lung upon recall, indicating that they behaved similar to functional memory T cells; that is, they produced IFN-g and mediated resistance against a lethal pulmonary infection.
The availability of this tg mouse will enable investigators to study the earliest stages of priming and differentiation of fungal Ag-specific T cells and examine the requirements for maintaining long-term memory of protective T cells. Our work demonstrates that insights from a fungal model differ from viral or bacterial models (33, 43) , for example vis-à-vis duration of Ag persistence. Other tg models also emphasize using very low precursor frequencies to portray Ag-specific T cell responses, but we found that a frequency of 10 5 precursors enabled optimal in vivo expansion. We also found that this frequency was needed to analyze recall responses in the lung and preserve key functions such as IFN-g production in vivo and resistance to infection. We expect that the better resolving power of 1807 cells over polyclonal analysis will enable us to explore and answer critical questions in fungal immunology, including: 1) the occurrence and importance of Agspecific T cell differentiation down various T helper pathways in establishing protective immunity; 2) the contribution of distinct APC populations in vaccine priming of Ag-specific T cell immunity to fungi; 3) the tissue specific influences on priming T cell immunity, for example in lung versus skin; and 4) the presence of shared Ags in the fungal kingdom that are recognized by protective T cells, such as those used to generate the Bd 1807 mouse described in this study.
